CONMED (NYSE:CNMD) Given New $120.00 Price Target at Stifel Nicolaus
CONMED (NYSE:CNMD – Free Report) had its target price lowered by Stifel Nicolaus from $136.00 to $120.00 in a research report released on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities research analysts have also recently commented on the company. Piper Sandler raised their […]
More Stories
ETRACS Quarterly Pay 1.5X Leveraged Wells Fargo BDC Index ETN (BDCX) to Issue Dividend of $1.24 on October 21st
ETRACS Quarterly Pay 1.5X Leveraged Wells Fargo BDC Index ETN (NYSEARCA:BDCX – Get Free Report) declared a dividend on Wednesday,...
Owens Corning (NYSE:OC) Trading 4.4% Higher on Analyst Upgrade
Owens Corning (NYSE:OC – Get Free Report) shares were up 4.4% during mid-day trading on Monday after Wells Fargo &...
Canadian Natural Resources (NYSE:CNQ) Stock Price Up 3.7% After Dividend Announcement
Canadian Natural Resources Limited (NYSE:CNQ – Get Free Report) (TSE:CNQ)’s stock price was up 3.7% during trading on Monday following...
Company Recalls Nearly 10 Million Pounds of Ready-to-Eat Meat, Poultry Over Listeria Risk
By Naveen Athrappully Oklahoma-based BrucePac is pulling millions of pounds of meat items from across the United States due to...
DeSantis, Florida Officials Issue Warnings to Would-Be Looters Ahead of Hurricane Milton
By Jack Phillips Officials in Florida issued stark warnings to would-be looters during Hurricane Milton that they could get shot...
Low Vitamin D Levels Linked to Slower Healing in Children’s Fractures
By George Citroner Research presented at the American Academy of Pediatrics (AAP) 2024 National Conference & Exhibition underscores the critical...